A new study found that 83.3% of practitioners believe biosimilars are just as effective and safe as originator drugs. Yet, because of knowledge gaps related to biosimilars, patients fear disease flares caused by biosimilars, as well as the drug’s effectiveness.
Taking inspiration from rheumatologists' efforts, gastroenterologists are seeking to identify progressive disease markers, assess drug efficacy, and identify mechanisms of inefficacy.
With this massive 800-page two-volume book, Paolo Pesaresi plugs one of the few remaining gaps in the ANR story by reconstructing the history of the II Gruppo Caccia (2nd Fighter Group), a subject he first through a chance meeting with an ANR veteran.